Total Payments
$59,814
2023 Payments
$3.08
Companies
23
Transactions
66
Medicare Patients
3,820
Medicare Billing
$415,268
Payment Breakdown by Category
Consulting$58,500 (97.8%)
Food & Beverage$1,311 (2.2%)
Education$3.08 (0.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $58,500 | 6 | 97.8% |
| Food and Beverage | $1,311 | 59 | 2.2% |
| Education | $3.08 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $58,500 | 6 | $0 (2019) |
| Amgen Inc. | $246.03 | 9 | $0 (2019) |
| Keryx Biopharmaceuticals, Inc. | $199.19 | 3 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $95.41 | 4 | $0 (2019) |
| OPKO Pharmaceuticals, LLC | $90.37 | 6 | $0 (2018) |
| AKEBIA THERAPEUTICS INC | $87.14 | 2 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $70.43 | 4 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $64.63 | 4 | $0 (2020) |
| Takeda Pharmaceuticals America, Inc. | $63.71 | 6 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $46.75 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $3.08 | 1 | Travere Therapeutics, Inc. ($3.08) |
| 2020 | $19.05 | 1 | Otsuka America Pharmaceutical, Inc. ($19.05) |
| 2019 | $58,862 | 21 | PFIZER INC. ($58,500) |
| 2018 | $544.41 | 20 | Keryx Biopharmaceuticals, Inc. ($199.19) |
| 2017 | $385.53 | 23 | Takeda Pharmaceuticals America, Inc. ($63.71) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 02/10/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: NEPHROLOGY | ||||||
| 12/23/2019 | PFIZER INC. | EUCRISA (Drug) | Consulting Fee | Cash or cash equivalent | $2,040.00 | General |
| Category: DERMATOLOGY | ||||||
| 12/02/2019 | Baxter Healthcare | Renal - PD (Device) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Renal | ||||||
| 11/18/2019 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $4,320.00 | General |
| 10/14/2019 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $420.00 | General |
| 09/30/2019 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $14,940.00 | General |
| 09/16/2019 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Nephrology | ||||||
| 08/12/2019 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $9,900.00 | General |
| 08/12/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/29/2019 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $19.84 | General |
| 07/15/2019 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $26,880.00 | General |
| 07/15/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.41 | General |
| Category: Cardiovascular | ||||||
| 07/15/2019 | Baxter Healthcare | Renal - Amia (Device) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: Renal | ||||||
| 06/18/2019 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.20 | General |
| Category: NEPHROLOGY | ||||||
| 06/15/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug), JYNARQUE | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: NEPHROLOGY | ||||||
| 05/13/2019 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Nephrology | ||||||
| 04/29/2019 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $30.28 | General |
| Category: Immunology | ||||||
| 04/15/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/04/2019 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/18/2019 | Amgen Inc. | Parsabiv (Biological) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: Nephrology | ||||||
| 01/29/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 01/17/2019 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | Cash or cash equivalent | $64.94 | General |
| Category: NEPHROLOGY | ||||||
| 11/19/2018 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: BioOncology/Immunology | ||||||
| 11/13/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Uloric (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: Gout/Rheumatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 176 | 313 | $87,075 | $29,616 |
| 2022 | 3 | 181 | 333 | $92,600 | $31,678 |
| 2021 | 23 | 1,188 | 3,414 | $368,584 | $118,842 |
| 2020 | 23 | 2,275 | 7,084 | $758,274 | $235,131 |
Total Patients
3,820
Total Services
11,144
Medicare Billing
$415,268
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 254 | $76,200 | $24,788 | 32.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 29 | 38 | $5,700 | $3,674 | 64.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 21 | $5,175 | $1,154 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 137 | 277 | $83,100 | $26,797 | 32.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 26 | 34 | $5,100 | $3,501 | 68.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 22 | $4,400 | $1,380 | 31.4% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 35 | 151 | $129,920 | $44,120 | 34.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 190 | 333 | $101,500 | $32,226 | 31.7% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2021 | 13 | 1,748 | $42,558 | $11,761 | 27.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 44 | 161 | $32,015 | $9,910 | 31.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 23 | 53 | $12,638 | $4,688 | 37.1% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2021 | 75 | 77 | $8,855 | $3,179 | 35.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 28 | 32 | $4,470 | $2,741 | 61.3% |
| 82306 | Vitamin d-3 level | Office | 2021 | 66 | 68 | $5,576 | $2,013 | 36.1% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 11 | 11 | $4,950 | $1,680 | 33.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 22 | $4,480 | $1,663 | 37.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 13 | 61 | $5,170 | $764.94 | 14.8% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2021 | 84 | 89 | $4,450 | $752.94 | 16.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 69 | 74 | $1,628 | $574.98 | 35.3% |
| 82728 | Ferritin (blood protein) level | Office | 2021 | 32 | 33 | $1,254 | $449.79 | 35.9% |
| 82040 | Albumin (protein) level | Office | 2021 | 74 | 76 | $1,140 | $376.20 | 33.0% |
| 84100 | Phosphate level | Office | 2021 | 76 | 78 | $1,170 | $369.72 | 31.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2021 | 66 | 68 | $1,020 | $352.24 | 34.5% |
| 83550 | Iron binding capacity | Office | 2021 | 32 | 33 | $825.00 | $288.42 | 35.0% |
| 84156 | Total protein level, urine | Office | 2021 | 66 | 68 | $3,060 | $249.56 | 8.2% |
About Dr. David Simon, MD
Dr. David Simon, MD is a Nephrology healthcare provider based in Orange, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1811983125.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Simon, MD has received a total of $59,814 in payments from pharmaceutical and medical device companies, with $3.08 received in 2023. These payments were reported across 66 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($58,500).
As a Medicare-enrolled provider, Simon has provided services to 3,820 Medicare beneficiaries, totaling 11,144 services with total Medicare billing of $415,268. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Orange, CT
- Active Since 09/22/2005
- Last Updated 04/11/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1811983125
Products in Payments
- EUCRISA (Drug) $2,040
- Parsabiv (Biological) $215.13
- Auryxia (Drug) $199.19
- Uloric (Drug) $134.14
- SOLIRIS (Drug) $95.41
- Rayaldee (Drug) $90.37
- AURYXIA (Drug) $87.14
- ENTRESTO (Drug) $46.75
- SAMSCA (Drug) $45.58
- Tekturna (Drug) $43.56
- GATTEX (Drug) $40.35
- Rituxan (Biological) $35.30
- Veltassa (Drug) $31.78
- Sensipar (Drug) $30.90
- ELIQUIS (Drug) $24.41
- LOKELMA (Drug) $22.17
- Renal - Amia (Device) $21.20
- FABRAZYME (Drug) $21.08
- ACTHAR (Biological) $20.04
- JYNARQUE (Drug) $19.05
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Orange
Dr. Yasir Qazi, M.d, M.D
Nephrology — Payments: $613,561
Nephrology $613,561
Dr. Kamyar Kalantar-Zadeh, M.d, M.D
Nephrology — Payments: $502,256
Nephrology $502,256
Dr. Ramy Hanna, M.d, M.D
Nephrology — Payments: $373,673
Nephrology $373,673
Dr. Rebecca Ahdoot, M.d, M.D
Nephrology — Payments: $54,072
Nephrology $54,072
Kevin Pham, M.d, M.D
Nephrology — Payments: $25,425
Nephrology $25,425
Thu Le, M.d, M.D
Nephrology — Payments: $19,032
Nephrology $19,032